Latest Commercialization News

EBR Systems has successfully completed a heavily oversubscribed Security Purchase Plan, raising a total of A$75.9 million alongside a prior institutional placement to fund its innovative wireless cardiac pacing technology through 2027.

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

Activeport Group has secured over $1.2 million in new Network-as-a-Service orders across Sydney and Melbourne, marking a strong market debut for its Global Edge platform. The company’s innovative self-service network offering is set to drive significant revenue growth in FY26.

Ark Mines has launched a detailed metallurgical improvement program at its Sandy Mitchell Rare Earth and Heavy Minerals project, aiming to refine processing techniques and expand its resource base. The work supports a Pre-Feasibility Study due early next year.

Vanadium Resources has signed a non-binding MoU with China Precious Asia Limited to supply vanadium-rich magnetite ore from its Steelpoortdrift project, aiming for early production and cashflow. This marks a strategic pivot to monetise its vast resource amid subdued vanadium markets.

Diatreme Resources’ Northern Silica Project has been awarded Major Project Status by the Australian Government, marking a pivotal step in advancing critical minerals development in Queensland. This designation streamlines federal approvals and supports the project’s role in the clean energy supply chain.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Beetaloo Energy has begun hydraulic stimulation on its record-length Carpentaria-5H well in the Beetaloo Basin, aiming to unlock enhanced gas production with advanced techniques. Results from the upcoming production test will be pivotal for the company’s pilot project and future development plans.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.

Dubber Corporation has initiated court proceedings against its former auditors following a $26.6 million misappropriation uncovered in FY24, aiming to restore financial stability by year-end.

Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.

Element 25 has locked in a $50 million senior debt facility from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, underpinning supply for its US battery materials plant.